Developer of drugs based on dihydro folate reductase (DHFR) inhibitors. The company develops DHFR-inhibiting therapeutics with applications in the treatment of inflammatory bowel disease (IBD), ulcerative colitis, and Crohn's disease.
SoftCure Headquarter Location
Solna, 171 65,
46 70 302 95 88
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.